Presents the complicated process of CNS drug development in a way that is engaging and informative for professionals and students.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Amir Kalali is Vice President, Medical and Scientific Services, and Global Therapeutic Team Leader (CNS) at Quintiles Inc. He is also Professor of Psychiatry at the University of California San Diego, San Diego, CA, USA.
Sheldon Preskorn is Professor and Chairman, Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine, Wichita, KS, USA.
Joseph Kwentus is Clinical Professor at the University of Mississippi Medical Center, Jackson, MS, USA.
Stephen M. Stahl is Adjunct Professor of Psychiatry at the University of California San Diego, San Diego, and the Neuroscience Education Institute, Carlsbad, CA, USA.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : ThriftBooks-Dallas, Dallas, TX, Etats-Unis
Hardcover. Etat : Very Good. No Jacket. Missing dust jacket; May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less 1.2. N° de réf. du vendeur G0521766060I4N01
Quantité disponible : 1 disponible(s)
Vendeur : Project HOME Books, Philadelphia, PA, Etats-Unis
Etat : Good. shelf wear, hardcover Used - Good 2012 New All purchases support Project HOME - ending homelessness in Philadelphia. N° de réf. du vendeur CT10-000070
Quantité disponible : 1 disponible(s)
Vendeur : HPB-Red, Dallas, TX, Etats-Unis
Hardcover. Etat : Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! N° de réf. du vendeur S_446868921
Quantité disponible : 1 disponible(s)
Vendeur : RIVERLEE BOOKS, Waltham Cross, HERTS, Royaume-Uni
Hardcover. Etat : Good. 1st Edition. Unread but may have "damaged" stamp on one of the title pages due to cosmetic imperfection such as minor dents on cover or edge of pages or scratches on cover etc. N° de réf. du vendeur 060646
Quantité disponible : 1 disponible(s)
Vendeur : Buchmarie, Darmstadt, Allemagne
Etat : Good. N° de réf. du vendeur 3294823_3cf_3x
Quantité disponible : 1 disponible(s)
Vendeur : Toscana Books, AUSTIN, TX, Etats-Unis
Hardcover. Etat : new. Excellent Condition.Excels in customer satisfaction, prompt replies, and quality checks. N° de réf. du vendeur Scanned0521766060
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Hardcover. Etat : Brand New. 1st edition. 218 pages. 9.37x6.14x0.63 inches. In Stock. This item is printed on demand. N° de réf. du vendeur __0521766060
Quantité disponible : 1 disponible(s)
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9780521766067_new
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 12331330-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. Central Nervous System disorders have an enormous impact on individuals and on society as a whole. The development of better treatments is crucial and is a major focus of pharmaceutical and biotechnology companies. This book explains the complicated process of CNS drug development in a way that is engaging for any interested professional or student. Chapters cover each stage of drug development, from pre-clinical research through all phases of clinical trials, to reporting to the regulatory authorities. Other key issues covered include strategic considerations, regulatory constraints, dissemination of results and ethical considerations. The user-friendly format and style enable readers to find important information quickly and easily. Written and edited by experts from different sectors actively engaged in CNS drug development, this is a unique resource for drug developers, investigators, academics and clinicians. Written and edited by experts from different sectors actively engaged in CNS drug development, this book presents the complicated process of CNS drug development in a way that is engaging and informative for any interested professional or student. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9780521766067
Quantité disponible : 1 disponible(s)